Skip to main content
Equibles

Palo Alto Investors LP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1306923 PALO ALTO, CA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$9,475,311
+$3,255,834 QoQ
Shares Held
1,391,382
0.0% QoQ
Ownership
0.427%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#39
of 208 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Palo Alto Investors LP holds $594,195,112 across 39 Biotechnology names. TSHA ranks #19 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 918,846 $74,950,268
2 ACAD
Acadia Pharmaceuticals Inc
 2,864,096 $72,461,628
3 INSM
INSMED Inc
 413,980 $44,138,547
4 MIRM
Mirum Pharmaceuticals, Inc.
 348,808 $40,834,952
5 ANAB
Anaptysbio, Inc
 603,489 $40,735,507
6 BMRN
Biomarin Pharmaceutical Inc
 682,777 $39,068,499
7 DYN
Dyne Therapeutics, Inc.
 1,647,521 $36,591,441
8 IRON
Disc Medicine, Inc.
 416,646 $30,473,488

All Filings in TSHA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,475,311 1,391,382
2026-03-31 $6,219,477 1,391,382
2025-12-31 $6,507,572 1,183,195
2025-09-30 $4,074,527 1,246,033
2025-06-30 $2,878,336 1,246,033
2025-03-31 $1,973,060 1,419,468
2024-12-31 $1,403,493 811,268
2024-09-30 $1,630,648 811,268
2024-06-30 $1,817,240 811,268
2024-03-31 $2,328,339 811,268
2023-12-31 $937,853 529,861